Insights

Global Export Market Bio Farma's extensive export operations to 117 countries present significant opportunities to expand product offerings and develop new vaccine formulations tailored to international markets, leveraging their established global distribution network.

Strategic Collaborations Ongoing partnerships with leading vaccine developers like Serum Institute, Merck, and Biological E indicate a strong foundation for co-developing new vaccines, including emerging infectious disease vaccines, opening avenues for joint sales initiatives.

Vaccine Innovation Focus Recent investments in developing HPV and Tdap vaccines demonstrate Bio Farma’s commitment to expanding its product portfolio, providing potential for upselling advanced or complementary vaccines to healthcare providers and government agencies.

Recent Industry Leadership Hosting major industry events such as the 26th DCVMN AGM and leading vaccine manufacturing initiatives positions Bio Farma as a key player in the global vaccine landscape, facilitating partnership opportunities and cross-selling of mRNA and pandemic preparedness solutions.

Vaccine Independence Drive Bio Farma's focus on vaccine independence and enhancing health resilience offers opportunities to sell supplementary products, technologies, and consulting services that support local vaccine production and infrastructure development.

Similar companies to Bio Farma - Indonesia

Bio Farma - Indonesia Tech Stack

Bio Farma - Indonesia uses 8 technology products and services including Slick, jQuery, Select2, and more. Explore Bio Farma - Indonesia's tech stack below.

  • Slick
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Select2
    Javascript Libraries
  • Google Maps
    Maps
  • reCAPTCHA
    Security
  • X-Content-Type-Options
    Web & Portal Technology
  • AddToAny
    Widgets
  • Twitter
    Widgets

Media & News

Bio Farma - Indonesia's Email Address Formats

Bio Farma - Indonesia uses at least 1 format(s):
Bio Farma - Indonesia Email FormatsExamplePercentage
First.Last@biofarma.co.idJohn.Doe@biofarma.co.id
97%
First@biofarma.co.idJohn@biofarma.co.id
2%
First.L@biofarma.co.idJohn.D@biofarma.co.id
1%

Frequently Asked Questions

What is Bio Farma - Indonesia's phone number?

Minus sign iconPlus sign icon
You can contact Bio Farma - Indonesia's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Bio Farma - Indonesia's official website and social media links?

Minus sign iconPlus sign icon
Bio Farma - Indonesia's official website is biofarma.co.id and has social profiles on LinkedInCrunchbase.

What is Bio Farma - Indonesia's NAICS code?

Minus sign iconPlus sign icon
Bio Farma - Indonesia's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Bio Farma - Indonesia have currently?

Minus sign iconPlus sign icon
As of December 2025, Bio Farma - Indonesia has approximately 1.3K employees across 5 continents, including AsiaEuropeSouth America. Key team members include Vp Digital & It: S. N.Vice President Corporate & Subsidiary Performance Management: R. K. P.Vice President Of Domestic Marketing & Sales: F. P.. Explore Bio Farma - Indonesia's employee directory with LeadIQ.

What industry does Bio Farma - Indonesia belong to?

Minus sign iconPlus sign icon
Bio Farma - Indonesia operates in the Pharmaceutical Manufacturing industry.

What technology does Bio Farma - Indonesia use?

Minus sign iconPlus sign icon
Bio Farma - Indonesia's tech stack includes SlickjQuerySelect2Google MapsreCAPTCHAX-Content-Type-OptionsAddToAnyTwitter.

What is Bio Farma - Indonesia's email format?

Minus sign iconPlus sign icon
Bio Farma - Indonesia's email format typically follows the pattern of First.Last@biofarma.co.id. Find more Bio Farma - Indonesia email formats with LeadIQ.

How much funding has Bio Farma - Indonesia raised to date?

Minus sign iconPlus sign icon
As of December 2025, Bio Farma - Indonesia has raised $450M in funding. The last funding round occurred on Mar 31, 2021 for $450M.

Bio Farma - Indonesia

Pharmaceutical ManufacturingWest Java, Indonesia1001-5000 Employees

BIO FARMA adalah perusahaan milik negara yang mengkhususkan kegiatan bisnisnya dalam memproduksi vaksin dan sera. Bio Farma didirikan oleh Pemerintah Belanda pada tanggal 6 Agustus tahun 1890 di Jakarta dengan nama PARC VACCINOGEN. Seiring dengan meningkatnya kegiatan produksi, tahun 1923, lembaga ini mengalihkan pusat kegiatan produksinya ke Bandung, tepatnya terletak di jalan Pasteur no 28 - bersebelahan dengan Rumah Sakit Hasan Sadikin.

Saat tanah Nusantara diduduki oleh Jepang (1942 - 1945), lembaga ini diambil alih oleh Pemerintah Jepang, dan namanya berganti menjadi BANDUNG BOEKI KENKYUSHOO. Kegiatan produksi vaksin dan sera masih terus dipertahankan.

Setelah Indonesia merdeka, lembaga ini beralih ke tangan Pemerintah Indonesia (1946). Dr. R.M. Sardjito merupakan orang pertama yang dipercaya untuk memimpin lembaga ini. Dengan perjalan waktu yang panjang, lembaga ini telah banyak mengalami perubahan nama, pernah menyandang nama Perusahaan Negara Pasteur, Perusahaan Umum Bio Farma, dan sekarang PT Bio Farma (Persero).

Produk Bio Farma terdiri dari; vaksin BCG, vaksin DTP-HB, vaksin DT, vaksin Td, vaksin Hepatitis B, vaksin Polio, vaksin Campak, vaksin Influenza, serum anti bisa ular, serum anti difteri, serum anti tetanus. Sebagai perusahaan milik Negara, Bio Farma mendedikasikan diri untuk pemenuhan kebutuhan vaksin Dalam Negeri. sisa kapasitas yang tidak terserap oleh kebutuhan dalam Negeri, Bio Farma mengekspor produk-produknya ke 117 negara.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
1001-5000

Section iconFunding & Financials

  • $450M

    Bio Farma - Indonesia has raised a total of $450M of funding over 1 rounds. Their latest funding round was raised on Mar 31, 2021 in the amount of $450M.

  • $100M$250M

    Bio Farma - Indonesia's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $450M

    Bio Farma - Indonesia has raised a total of $450M of funding over 1 rounds. Their latest funding round was raised on Mar 31, 2021 in the amount of $450M.

  • $100M$250M

    Bio Farma - Indonesia's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.